ArticleThe journal of ECT2026
Electroconvulsive Therapy and the Longitudinal Modulation of Sleep Architecture.
Article in The journal of ECT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundSleep plays a critical role in mood regulation, yet the mechanisms linking sleep to mood improvement remain unclear. Electroencephalographic (EEG) slow-wave activity (SWA) during non-rapid eye movement (NREM) sleep is reduced in patients with major depressive disorder. Here, we examined sleep architecture in patients with depression undergoing electroconvulsive therapy (ECT).
methodsSleep EEG data were collected using wireless Dreem devices before and after each ECT session serially throughout the ECT course. Sleep stages were manually scored into rapid eye movement (REM) and NREM stages (N1-N3) according to modified American Academy of Sleep Medicine guidelines. Depression severity was assessed using the 16-Item Quick Inventory of Depressive Symptomatology-Self Report (QIDS). SWA was quantified as the average 0.5-4 Hz frontal EEG power per minute during N2 and N3 sleep.
resultsAcross 214 sleep records from 22 subjects (median 9 per patient), the percentage of time in N3 sleep increased over the course of therapy in the responders' group (P=0.030). SWA increased throughout the ECT course across all participants (P=0.001), and it was negatively correlated with the QIDS score (P<0.001). Mediation analysis revealed that SWA mediated the effect of treatment on QIDS only in the responders' group (P=0.037).
conclusionOur findings demonstrate that ECT increases N3 sleep and SWA in the responders' group, with SWA changes mediating improvements in depressive symptoms. These findings highlight SWA as a biomarker of antidepressant response and a potential target for sleep-based strategies to augment brain stimulation therapies for depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.